Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nessa Carey

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Drug Discovery Today. Technologies|July 17, 2014
Editorial: epigeneticsNessa Carey
Drug Discovery Today|October 27, 2010
Epigenetic therapies for non-oncology indicationsJonathan D Best, Nessa Carey
Drug Discovery Today|November 10, 2009
Epigenetic opportunities and challenges in cancerJonathan D Best, Nessa Carey
Obstetric Medicine|March 1, 2013
The Epigenetics of Normal PregnancyJonathan D Best, Nessa Carey
Current Opinion in Pharmacology|June 20, 2006
Histone deacetylase inhibitors: gathering paceNessa Carey, Nicholas B La Thangue
Drug Discovery Today|May 24, 2011
DNA demethylases: a new epigenetic frontier in drug discoveryNessa Carey, C Joana Marques, Wolf Reik
American Journal of Physiology. Heart and Circulatory Physiology|February 14, 2004
Flow-dependent increase of ICAM-1 on saphenous vein endothelium is sensitive to apaminSabena Sultan, Martin Gosling, Shadi Abu-Hayyeh, et al.
Atherosclerosis|January 5, 2002
Generation and characterisation of human saphenous vein endothelial cell linesAriane Scoumanne, Tahereh Kalamati, Jill Moss, et al.
Molecular Cancer Therapeutics|January 14, 2009
Genomics screen in transformed stem cells reveals RNASEH2A, PPAP2C, and ADARB1 as putative anticancer drug targetsJames M Flanagan, Juan M Funes, Stephen Henderson, et al.
Nature Communications|January 30, 2016
Non-CG DNA methylation is a biomarker for assessing endodermal differentiation capacity in pluripotent stem cellsLee M Butcher, Mitsuteru Ito, Minodora Brimpari, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Drug Discovery Today. Technologies|July 17, 2014
Editorial: epigeneticsNessa Carey
Drug Discovery Today|October 27, 2010
Epigenetic therapies for non-oncology indicationsJonathan D Best, Nessa Carey
Drug Discovery Today|November 10, 2009
Epigenetic opportunities and challenges in cancerJonathan D Best, Nessa Carey
Obstetric Medicine|March 1, 2013
The Epigenetics of Normal PregnancyJonathan D Best, Nessa Carey
Current Opinion in Pharmacology|June 20, 2006
Histone deacetylase inhibitors: gathering paceNessa Carey, Nicholas B La Thangue
Drug Discovery Today|May 24, 2011
DNA demethylases: a new epigenetic frontier in drug discoveryNessa Carey, C Joana Marques, Wolf Reik
American Journal of Physiology. Heart and Circulatory Physiology|February 14, 2004
Flow-dependent increase of ICAM-1 on saphenous vein endothelium is sensitive to apaminSabena Sultan, Martin Gosling, Shadi Abu-Hayyeh, et al.
Atherosclerosis|January 5, 2002
Generation and characterisation of human saphenous vein endothelial cell linesAriane Scoumanne, Tahereh Kalamati, Jill Moss, et al.
Molecular Cancer Therapeutics|January 14, 2009
Genomics screen in transformed stem cells reveals RNASEH2A, PPAP2C, and ADARB1 as putative anticancer drug targetsJames M Flanagan, Juan M Funes, Stephen Henderson, et al.
Nature Communications|January 30, 2016
Non-CG DNA methylation is a biomarker for assessing endodermal differentiation capacity in pluripotent stem cellsLee M Butcher, Mitsuteru Ito, Minodora Brimpari, et al.
Pageof 2